Renal handling of albumin: A critical review of basic concepts and perspective

American Journal of Kidney Diseases

Volumn 39, Issue 5, 2002, Pages 899-919

  Russo, Leileata M ^a,b   Bakris, George L ^a,b   Comper, Wayne D ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Albumin receptors; Albumin retrieval pathway; Albuminuria; Charge selectivity; Glomerular size selectivity; Large pores; Lysosomal activity; Urine protein fragments

Indexed keywords

ALBUMIN; ALBUMIN RECEPTOR; PEPTIDE FRAGMENT;

GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS FILTRATION; HUMAN; KIDNEY CLEARANCE; KIDNEY FUNCTION; MOLECULAR SIZE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN PROCESSING; PROTEIN URINE LEVEL; PROTEINURIA; REVIEW; URINARY EXCRETION;

EID: 0036240467     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2002.32764     Document Type: Article

References (190)

1. Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage
2. Fractional clearance of high molecular weight proteins in conscious rats using a continuous infusion method
3. Lipoprotein degradation by the kidney in proteinuric states: Role in interstitial injury
4. Variability of standard clinical protein assays in the analysis of a model urine solution of fragmented albumin
5. Protein fragments in urine have been considerably underestimated by various protein assays
6. Alterations in the renal degradation of albumin in early experimental diabetes: A new factor in the mechanism of albuminuria
7. Glomerular permselectivity factors are not responsible for the increase in fractional clearance of albumin in rat glomerulonephritis
8. 125I-labeled homologous albumin by rat kidney proximal cells. A study of microperfused single proximal tubules by electron microscopic autoradiography and histochemistry
9. Degradation and regurgitation of extracellular proteins by cultured mouse peritoneal macrophages and baby hamster kidney fibroblasts
10. Secretion of intact proteins and peptide fragments by lysosomal pathways of protein degradation
11. Glomerular capillary wall permeability to albumin and horseradish peroxidase
12. Glomerular charge selectivity for anionic and neutral horseradish peroxidase
13. Protein degradation during renal passage in normal kidneys is inhibited in experimental albuminuria
14. Competition between low- and high-molecular-weight proteins for renal tubular uptake
15. Renal tubular uptake of protein: Effect of molecular charge
16. Serum albumin
17. Three dimensional structure of human serum albumin
18. Crystal structure of human serum albumin at 2.5 Å resolution
19. Permselectivity of the glomerular capillary wall. III. Restricted transport of polyanions
20. Permselectivity of the glomerular capillary wall to macromolecules. II. Experimental studies in rats using neutral dextrans
21. Permselectivity of the glomerular capillary wall. Studies of experimental glomerulonephritis in the rat using dextran sulfate
22. Desulphation of dextran sulphate during kidney ultrafiltration
23. Glomerular processing of dextran sulphate
24. Charge selectivity in kidney ultrafiltration is associated with glomerular uptake of transport probes
25. The uptake of dextran sulfate by glomerular intracellular vesicles during kidney ultrafiltration
26. Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans
27. Effects of angiotensin II receptor blockade on remnant glomerular permselectivity
28. Assessment of charge-selectivity of glomerular basement membrane using Ficoll sulfate
29. Anomalous decrease in dextran sulfate clearance in the diabetic rat kidney
30. Glomerular permeability of macromolecules. Effect of molecular configuration on the fractional clearance of uncharged dextran and neutral horseradish peroxidase in the rat
31. Glomerular permeability and polyanion in Adriamycin nephrosis in the rat
32. Tubular inhibition destroys charge selectivity for anionic and neutral horseradish peroxidase
33. Size and charge selectivity of glomerular filtration in type I (insulin dependent) diabetic patients with and without albuminuria
34. Glomerular charge selectivity in type I (insulin-dependent) diabetes mellitus
35. Glomerular size and charge selectivity in type 2 (non insulin-dependent) diabetic patients with diabetic nephropathy
36. Charge selectivity and urine amylase isoenzymes
37. Glomerular permselectivity in healthy and nephrotic humans
38. The exclusion of large solutes by cartilage protein polysaccharide
39. The interaction between polysaccharides and other macromolecules: 9. The exclusion of molecules from hyaluronic acid gels and solutions
40. Interaction between serum albumin and acidic polysaccharides
41. The exclusion of protein by hyaluronic acid
42. Exclusion in hyaluronate gels
43. A codiffusing system as a novel model for capillary wall charge selectivity
44. On the interaction between polysaccharides and other macromolecules. II: The transport of globular particles through hyaluronic acid solutions
45. On the transport of compact particles through solutions of chain-polymers
46. Physicochemical properties of articular cartilage
47. The role of water, proteoglycan, and collagen in solute transport in cartilage
48. Distribution of serum albumin in human normal and degenerate cartilage
49. Glomerular size and charge selectivity in the rat as revealed by FITC-Ficoll and albumin
50. A quantitative analysis of the glomerular charge barrier in the rat
51. Charge selectivity is a concept that is yet to be demonstrated
52. Characteristics of the glomerular capillary membrane of the rat kidney as a hydrated gel. II. On the validity of the model
53. Exchange of macromolecules across the microcirculation
54. Exclusion of plasma proteins in interstitium of tissues from dog hind paw
55. Effects of histamine and some other substances on molecular selectivity of the capillary wall to plasma proteins and dextran
56. Transport of large molecules from plasma to interstitial fluid and lymph in dogs
57. Comparative analysis of the protein content of local subcutaneous tissue fluid and plasma
58. Protein concentration in interstitial and lymphatic fluids from the subcutaneous tissue
59. Dextrans as test molecules in studies of the functional ultrastructure of biological membranes
60. Concentration of trypsin inhibitors of different molecular size and of albumin and haptoglobulin in blood and lymph of various organs in the dog
61. Diuretics and small intestine lymph flow in the dog
62. Early kinetics of large molecule transport between plasma and lymph in dogs
63. Origin and molecular size of immunoglobulin-A in the mesenteric lymph of the dog
64. Glomerular function in Pima Indians with non-insulin-dependent diabetes mellitus of recent onset
65. Mechanisms of proteinuria in diabetic nephropathy: A study of glomerular barrier function
66. Glomerular size-selectivity and microalbuminuria in early diabetic glomerular disease
67. Alterations in the charge and size selectivity barrier of the glomerular filter in aminonucleoside nephrosis in rats
68. Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass
69. Determinants of glomerular hypofiltration in nephrotic patients with minimal change nephropathy
70. Changes in heparan sulfate correlate with increased glomerular permeability
71. Glomerular size-selective barrier dysfunction in nephrotoxic serum nephritis
72. Molecular configuration and glomerular size selectivity in healthy and nephrotic humans
73. Albuminuria in hypertension is linked to altered lysosomal activity and TGF-β 1 expression
74. Renal hypertrophy in STZ diabetic rats: Role of proteolytic lysosomal enzymes
75. Renal hypertrophy and kidney disease in diabetes
76. Renal proteinases and kidney hypertrophy in experimental diabetes
77. Tubular cell protein degradation in early diabetic renal hypertrophy
78. Proximal tubule reabsorption of growth hormone and sodium/fluid in normo- and microalbuminuric insulin-dependent diabetes mellitus
79. The return of glomerular filtered albumin to the rat renal vein
80. Ultrastructural evidence by immunohistochemical techniques for a tubular reabsorption of endogenous albumin and certain circulating protein in normal rat
81. The protein concentration in the proximal tubule
82. Micropuncture study of the concentration and fate of albumin in rat nephron
83. Protein excretion: Micropuncture study of rat capsular and proximal tubule fluid
84. Micropuncture studies of proximal tubule albumin concentration in normal and nephrotic rats
85. Micropuncture study of albumin transfer in aminonucleoside nephrosis in the rat
86. Glomerular protein filtration in normal and nephrotic rats. A micropuncture study
87. Effect of angiotensin on the filtration of protein in the rat kidney: A micropuncture study
88. Filtration of protein in the anti-glomerular basement membrane nephritic rat: A micropuncture study
89. Micropuncture studies of the filtration and absorption of albumin by nephrotic rats
90. Plasma protein handling in the rat kidney: Micropuncture experiments in the acute heterologous phase of anti-GBM-nephritis
91. Glomerular albumin filtration: A comparison of micropuncture studies in the isolated perfused kidney with in vivo experimental conditions
92. Glomerular albumin leakage and morphology after neutralisation of polyanions. I. Albumin clearance and sieving coefficient in the isolated perfused rat kidney
93. Pathophysiology of the kidney in rats with Heymann nephritis
94. Intrarenal handling of proteins in rats using fractional micropuncture technique
95. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border
96. Characterisation of the antigen (gp600) of Heymann nephritis
97. Complete cloning and sequencing of rat gp330/megalin, a distinctive member of the low density lipoprotein receptor gene family
98. 2+-sensing protein
99. Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/alpha 2MR, and the receptor associated protein (RAP)
100. Megalin is an endocytic receptor for insulin
101. 3
102. Evidence for the essential role of megalin in transepithelial transport of retinol
103. 12 homeostasis
104. Renal tubule gp 330 is a calcium binding receptor for endocytic uptake of protein
105. Megalin/gp 330 mediates uptake of albumin in renal proximal tubule
106. Transcytosis of retinol binding protein across renal proximal tubule cells after megalin (gp330)-mediated endocytosis
107. Segmental distribution of the endocytosis receptor gp 330 in renal proximal tubules
108. Receptor associated protein is important for normal processing of megalin in kidney proximal tubules
109. Purification, properties and immunochemical localisation of a receptor for intrinsic factor-cobalamin complex in the rat kidney
110. Identification of rat yolk sac target protein of teratogenic antibodies, gp280, as intrinsic factor-cobalamin receptor
111. Megalin and cubilin: Synergistic endocytic receptors in renal proximal tubule
112. 12 receptor and target of teratogenic antibodies is a megalin-binding peripheral membrane protein with homology to developmental proteins
113. Cubilin is an albumin binding protein important for renal tubular albumin reabsorption
114. 12)
115. Novel mechanism(s) implicated in tubular albumin reabsorption and handling
116. Albumin absorption and catabolism by isolated proximal tubules of the rabbit
117. Characterisation of albumin binding in opossum kidney cells and the identification of potential receptors
118. Functional characterisation of albumin binding to the apical membrane of OK cells
119. Receptor-mediated endocytosis of albumin in cultured opossum kidney cells: A model for proximal tubular protein reabsorption
120. Characterisation and distribution of albumin binding protein in normal rat kidney
121. Megalin knockout mice as an animal model of low molecular weight proteinuria
122. Defective forebrain development in mice lacking gp330/megalin
123. 12 malabsorption and proteinuria in young people. A syndrome
124. 12 receptor, cubilin, cause hereditary megaloblastic anaemia 1
125. Imerslund-Gräsbeck anemia. A long term follow up study
126. Inherited selective intestinal cobalamin malabsorption and cobalamin deficiency in dogs
127. Positionally cloned gene for a novel glomerular protein-nephrin is mutated in congenital nephrotic syndrome
128. Nephrin in experimental glomerular disease
129. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segment glomerulosclerosis
130. A simple method to detect an albumin permeability factor in the idiopathic nephrotic syndrome
131. Metabolic effects of fatty acid-bearing albumin on a proximal tubule cell line
132. Abnormalities in plasma concentrations of lipoproteins and fibrinogen in type I (insulin-dependent) diabetic patients with increased urinary albumin excretion
133. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure
134. Lipoprotein abnormalities as a risk factor for progressive nondiabetic renal disease
135. Permselectivity in thin membrane nephropathy
136. Severe proteinuria, sustained for 6 months, induces tubular epithelial cell injury and cell infiltration in rats but not progressive interstitial fibrosis
137. Podocyte loss and progressive glomerular injury in type II diabetes
138. Molecular basis of glomerular permselectivity
139. Production of the nephrotic syndrome in rats by Freund's adjuvant and rat kidney suspension
140. Role of abnormally high transmural pressure in the permselectivity defect of glomerular capillary wall: A study in early passive Heymann nephritis
141. Active Heymann nephritis in complement component C 6 deficient rats
142. Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy
143. Deficiency of megalin in the urine of patients with Dent's disease (CLCN5 mutation) and the Lowe syndrome indicates failure of normal endocytic receptor trafficking in these renal Fanconi syndromes
144. Role of megalin in renal handling of aminoglycosides
145. Inhibition of aminopeptidase A activity causes an acute albuminuria in mice: An angiotensin II-mediated effect?
146. Pathophysiology of progressive nephropathies
147. Effect of angiotensin-converting enzyme inhibition on glomerular basement membrane permeability and distribution of zonula occludens-1 in MWF rats
148. Evidence that TGF-β should be a therapeutic target in diabetic nephropathy
149. Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis
150. High glucose media enhance the responsiveness of tubular cells to growth promoters: Effect on lysosomal cathepsins and protein degradation
151. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
152. Concentrations and actions of intraluminal angiotensin II
153. Specific binding sites for albumin restricted to plasmalemmal vesicles of continuous capillary endothelium: Receptor-mediated transcytosis
154. Transendothelial transport of serum albumin: A quantitative immunocytochemical study
155. 12 in LLC-PK1 renal proximal tubule cells
156. Renal handling of serum proteins as studied by micropuncture techniques
157. Reduced perm-selectivity in isolated perfused rat kidneys following small elevations of glomerular capillary pressure
158. Effect of colloid volume expansion on glomerular barrier size-selectivity in humans
159. Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass
160. Role for angiotensin II in an overt functional proteinuria
161. Tyrosine kinase dependent expression of TGF-β induced by stretch in mesangial cells
162. Cyclic stretching forces selectively upregulates TGF-β isoforms in cultured rat mesangial cells
163. Stretch-induced collagen synthesis in cultured smooth muscle cells from rabbit aortic media and a possible involvement of angiotensin II and TGF-β
164. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome
165. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial
166. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
167. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
168. Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
169. Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy
170. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data
171. Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans
172. Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glomerulopathy
173. ACE inhibition and ANG II receptor blockade improve glomerular size selectivity in IgA nephropathy
174. Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade
175. + uptake induced by angiotensin II in primary cultured rabbit renal proximal tubule cells
176. Albumin endocytosis in OK cells: Dependence on actin and microtubules and regulation by protein kinases
177. Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalisation of glomerular protein kinase C
178. Ramipril and aminoguanidine restore lysosomal processing in streptozotocin diabetic rats
179. Transtubular leakage of glomerular filtrate in human acute renal failure
180. 4-Maleimidohippuric acid - A tailor-made, direct, site-specific nephrotoxin: Effects on renal function and ultrastructure in pentobarbital-anesthetized dogs
181. The inhibitory action of oxygen radical scavengers on proteinuria and glomerular heparan sulfate loss in the isolated perfused kidney
182. "Intact nephrons" as the primary origin of proteinuria in chronic disease
183. Loss of glomerular function and tubulointerstitial fibrosis: Cause or effect?
184. Tubulo-interstitial lesions mediate renal damage in Adriamycin glomerulopathy
185. Age-related nephropathy and proteinuria in rats with intact kidneys exposed to diets with different protein content
186. Noninvasive microscopic evaluation on the intact nephrotic kidney
187. Evaluation of a new fluorescent dye method to measure urinary albumin in lieu of urinary total protein
188. Underestimation of microalbuminuria by radioimmunoassay (RIA)-Its failure to detect denatured albumin and its fragments
189. Immuno-unreactive albumin excretion increases in streptozotocin diabetic rats